54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research is caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined.
As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
54gene aims to unlock the African genome by building the world’s first and largest pan-African biobank. Together with other pharmaceutical and biotech partners, we will study this dataset to identify diagnostic and therapeutic targets that benefit people all over the world.
Abasi Ene-Obong PhD
Chief Executive Officer
Chief Operations Officer
Chief Commercial Officer
VP of Engineering & Head of Technology, Africa
VP of Diagnostics & Country Head, Nigeria
Dr. Jumi Popoola
Director of Scientific Services, Africa
Dr. Zara Modibbo
VP Laboratory OperationsHead of Clinical Laboratory Services, Africa
Dr. Nabila Ado Wanka
Head of Histopathology
Director of Provider Engagement
Senior Manager, Ecosystem Partnerships, Africa
Chief of Staff